India to Zimbabwe: Dolutegravir Export Trade Route
India has recorded 267 verified shipments of Dolutegravir exported to Zimbabwe, representing a combined trade value of $31.6M USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $118.4K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 49% of total export value with 184 shipments worth $15.6M USD. On the buying side, MINISTRY OF HEALTH AND CHILD CARE is the largest importer in Zimbabwe with $13.4M USD in purchases. The top 3 suppliers — CIPLA LIMITED, EMCURE PHARMACEUTICALS LIMITED, LAURUS LABS LTD — together control 89% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Zimbabwe Dolutegravir corridor is one of India's established pharmaceutical export routes, with 267 shipments documented worth a combined $31.6M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's dolutegravir manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $118.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with dolutegravir's non-urgent bulk-order profile.
Shipment activity peaks during April-June, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 5%, placing it at rank #15 among India's top dolutegravir export destinations globally.
On the import side, key buyers of Indian dolutegravir in Zimbabwe include MINISTRY OF HEALTH AND CHILD CARE, MINISTRY OF HEALTH AND CHILD CARE HARARE, XXiteXXNatXXns XXvelXXmenXXProXXammX and 18 others. MINISTRY OF HEALTH AND CHILD CARE is the single largest importer with 81 shipments valued at $13.4M USD.
